w 12 has been researched along with Psoriasis in 1 studies
W 12: calmodulin antagonist; W13 analog with Cl deleted from benzene ring
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Pinter, A | 1 |
Puig, L | 1 |
Schäkel, K | 1 |
Reich, A | 1 |
Zaheri, S | 1 |
Costanzo, A | 1 |
Tsai, TF | 1 |
Smith, SD | 1 |
Lynde, C | 1 |
Brnabic, A | 1 |
Reed, C | 1 |
Hill, J | 1 |
Schuster, C | 1 |
Riedl, E | 1 |
Paul, C | 1 |
1 other study available for w 12 and Psoriasis
Article | Year |
---|---|
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO).
Topics: Adult; Arthritis, Psoriatic; Biological Products; Humans; Psoriasis; Severity of Illness Index; Sulf | 2022 |